Get the latest insights with syndromic testing webinars
Syndromic testing – the future of molecular diagnostics
Syndromic testing with the QIAstat-Dx system allows you to rapidly and simultaneously survey a large number of pathogens in a single sample. This means you can get comprehensive diagnostic answers in around an hour. And patients can get the right treatment faster.
To learn more about the benefits of QIAstat-Dx syndromic testing and hear about the latest insights on molecular diagnostics for infectious disease, watch our most recent webinars.
Watch the webinars
-
Learn why a clinical microbiology lab switched to QIAstat-Dx for meningitis/encephalitis
Title: Clinical impact of using syndromic testing for meningitis and encephalitis
Speaker: Xiaohui Nielsen, MD, PhD, Department of Clinical Microbiology, Zealand University Hospital, Denmark
Meningitis and encephalitis (M/E) result in considerable morbidity and mortality. Timely and accurate diagnosis is crucial for managing these infections. M/E syndromic panels are fast tests that can quickly identify a wide range of pathogens that cause M/E. Join Dr. Xiaohui Nielsen as she delves into published data and discusses her own experiences working with M/E panels. She walks through the benefits and caveats of these tests and approaches to clinical interpretation, and explains why her lab switched to the QIAstat-Dx Meningitis/Encephalitis Panel.
-
Learn how multiplex PCR testing contributes to the diagnosis of respiratory infections
Title: Multiplex versus low-plex testing for infectious illness – could you be underdiagnosing patients?
Speaker: Carmen Miravet Zaragoza, MSc Medical Science Liaison, Medical and Scientific Affairs, QIAGEN
Does low-plex PCR testing really contribute to the underdiagnosis of respiratory infections? And if so, by how much? Join Carmen Miravet as she presents a recent study comparing results from a theoretical low-plex viral respiratory assay with the multiplex QIAstat-Dx Respiratory SARS-CoV-2 Panel. She discusses how epidemiology analyses like this could help influence your diagnostic approach.
-
Learn why you should transition from culture to RT-PCR for GI testing
Title: How and why you should move from culture testing to a rapid, 1-step multiplex RT-PCR test for acute diarrhea
Speaker: Prof. Laurence Armand-Lefevre, University of Paris Cité & Bichat-Claude Bernard Hospital
Gastroenteritis is a leading cause of medical consultation and sometimes requires hospitalization. Microbiological diagnosis is essential for managing these illnesses, but they're under-diagnosed due to inefficient, low-sensitivity testing. Join Prof. Laurence Armand-Lefevre to hear how multiplex RT-PCR with QIAstat-Dx can help improve the diagnosis of gastroenteritis. You’ll learn about the performance and benefits of multiplex RT-PCR for gastroenteritis, the impact on patient care and the management of outbreaks and practical tips for bringing this molecular technique to your lab.
-
Learn how multiplex respiratory testing can support better care when it matters most
Title: Leveraging rapid multiplex testing during the height of respiratory season
Speaker: Anooj Shah, PharmD, MBA, BCIDP, Medical Science Liaison, Infectious Diseases, QIAGEN
Multiplex diagnostic testing increases opportunities for the detection of respiratory pathogens and can help avoid misdiagnosis due to overlapping clinical symptoms. By eliminating diagnostic uncertainty, these tests can help healthcare practitioners decide when to start or stop antimicrobial therapy with more confidence. Join Dr. Shah for this webinar as he walks through the benefits of multiplex diagnostic testing. He’ll focus on the unique benefits offered by the QIAstat-Dx multiplex diagnostic system, including real-time epidemiology tracking.
-
Learn how automated diagnostics can help improve care for patients with ARDS
Title: Rapid multiplex PCR diagnosis for viral respiratory infections in patients with respiratory distress syndrome using an innovative higher-throughput instrument
Speaker: Pr. Jérôme Le Goff, Professor of Virology at the Medicine Faculty of Université Paris Cité Saint-Louis Hospital, Paris, France
Patients admitted to the ICU for respiratory distress syndrome have a higher risk of mechanical ventilation and death if they present with a viral infection at admission. Quickly detecting respiratory viruses in this patient population could help identify those at higher risk of complications. Join Pr. Jérôme Le Goff as he discusses a study from his hospital assessing the impact of using an automated multiplex PCR system, the QIAstat-Dx Rise, for patients admitted to the ICU for acute distress syndrome.
-
Learn how rapid diagnostic tools can support antimicrobial stewardship programs
Title: Impact of antimicrobial stewardship intervention in conjunction with rapid multiplex respiratory diagnostics
Speaker: Eric Wenzler, PharmD, BCPS, BCIDP, AAHIVP, Department of Pharmacy Practice, University of Illinois, Chicago College of Pharmacy, USA
Quickly distinguishing between viral and bacterial causes of respiratory illness can lead to optimized antibacterial and antiviral use and assist with decisions on hospital admission and infection control. In this webinar, Dr. Wenzler explains how multiplex respiratory panels can enable quick and definitive pathogen identification to support antimicrobial stewardship efforts and optimize clinical and economic outcomes.
-
Learn how rapid multiplex panel tests can improve the diagnosis of gastroenteritis
Title: Improved diagnosis of gastrointestinal infections with a rapid PCR panel test
Speaker: Pierre Lureau Ph.D. Medical Director, Medical Biology Laboratory, Hospital Center of Niort, FranceAcute gastrointestinal (GI) infections are strikingly common. Worldwide, there are over 2 billion cases every year. Correctly diagnosing these infections can help healthcare providers deliver timely and efficient care. In this webinar, Pierre Lureau Ph.D., director of the Medical Biology Laboratory at the Hospital Center of Niort in Deux-Sèvres, France, explains how the QIAstat-Dx Gastrointestinal Panel has improved GI diagnostics at his institution. He describes how the panel has simplified the laboratory’s GI testing workflow, increased the detection of pathogens and improved medical services for in and outpatients.
-
Learn how syndromic panels can support the rapid diagnosis of critically ill patients
Syndromic panels for quick and effective diagnosis of meningitis and gastroenteritis
Speaker:Liliana Gabrielli, M.D., Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, ItalyWhen a patient is critically ill, a quick diagnosis is crucial. New multiplex molecular tools have the potential to speed up the timely and effective delivery of therapeutics. But how do these sensitive and specific multiplex tools compare to routine diagnostic approaches, like singleplex real-time PCR? In this webinar, Dr. Liliana Gabrielli evaluates the potential performance of rapid molecular syndromic testing for the etiological diagnosis of central nervous system and gastrointestinal infections.
-
Learn how a hospital lab validated our new multiplex panel test for meningitis/encephalitis
Title: Quickly diagnosing meningitis/encephalitis: Clinical validation of a rapid multiplex PCR panel test
Speaker: Thomas Sundelin Ph.D. Clinical Microbiology Department, Herlev Hospital, DenmarkInfections of the central nervous system (CNS) – meningitis and encephalitis – require immediate medical attention. Recent publications indicate that incorporating rapid multiplex PCR panel testing can speed up the time-to-diagnosis for CNS infections. In this webinar, Dr. Thomas Sundelin from the Clinical Microbiology Department at Herlev Hospital in Denmark discusses the clinical validation of QIAGEN’s rapid multiplex PCR test for CNS infections, the QIAstat-Dx Meningitis/Encephalitis Panel.
-
Learn what experts predict for future influenza-like illness seasons in a post-COVID-19 world
Title: Looking in the crystal ball: What will influenza-like illness season potentially look like post-COVID-19
pandemic?
Speaker: Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ, MD Anderson Cancer Center, USAThe COVID-19 pandemic has dramatically changed the way influenza-like illnesses are diagnosed and managed. In addition, the seasonality of respiratory pathogens has shifted, making it difficult to predict future respiratory seasons. In this webinar, Dr. Roy F. Chemaly of MD Anderson Cancer Center discusses the impact of the pandemic on the incidence of respiratory viruses. He also explains how the diagnostic tools used to detect these viruses has evolved, and why a comprehensive diagnostic approach is crucial going forward, especially for immunocompromised patients.
-
Learn how clinicians and laboratorians are working together to implement syndromic testing
Title: How is syndromic testing currently being used in the clinic and how will it impact diagnostics going forward?
Panel host: Davide Manissero, MD, MRCPCH, MSc, DTM&H, Chief Medical Officer, QIAGEN
Panel members: Stephan Gehring, Prof Dr Med, Children’s Hospital Universitätsmedizin Mainz, Germany Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ, MD Anderson Cancer Center, USA Susan A. Weaver, PhD, CLS, Natividad Medical Center, USA
As SARS-CoV-2 approaches endemic status, it will become increasingly important to quickly distinguish COVID-19 from other influenza-like illnesses. Multiplex PCR panel tests can detect and differentiate multiple pathogens at once. But how are these tests currently being used in the clinic and how will they impact diagnostics going forward? In this panel discussion, join three experts in infectious diseases as they discuss their personal experiences using multiplex testing and address pressing questions about this diagnostic approach.
-
Learn about the clinical outcomes of using dry swabs for respiratory syndromic testing
Title: The clinical outcomes of using dry swabs for respiratory syndromic testing
Speaker: Donia Bouzid, MD, PhD, Bichat Claude-Bernard Hospital, Emergency Department, FranceThis webinar discusses how multiplex syndromic testing using dry swab samples has positively impacted clinical decision making in a hospital in Paris, France. Dr. Donia Bouzid describes how prior to adopting multiplex PCR, Bichat Claude-Bernard Hospital experienced long wait times between the arrival of patients at the hospital and the diagnosis of respiratory infections. She then discusses how the faster turnaround time and comprehensive results provided by syndromic testing with the QIAstat-Dx Analyzer have influenced clinical outcomes at the hospital, including positively impacting single room assignment.
-
Learn about the role of multiplex testing in the COVID-19 pandemic
Title: Tackling COVID-19 through syndromic testing – QIAstat-Dx Respiratory SARS-CoV-2
Speaker: Davide Manissero, MD, MRCPCH, MSc, DTM&H, VP Head of Medical Affairs & Chief Medical Officer, Infection & Immune Diagnostics, QIAGENDuring this webinar, QIAGEN Chief Medical Officer Dr. Davide Manissero will discuss the role of multiplex respiratory PCR testing in the ongoing COVID-19 pandemic and how QIAGEN ramped up development efforts to be the first syndromic solution on the market. The importance of time to diagnosis and potential for co-infections as we approach the 2020-2021 influenza season will be discussed.
-
Learn about the benefits of syndromic testing for acute respiratory illness
Title: A new multiplex syndromic system for respiratory diagnosis and improved patient care
Speaker: Dr. Steve Young, Director of Research and Clinical Trials, TriCore Reference LaboratoriesThis webinar discusses how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections. Acute respiratory tract infections are caused by a wide range of viral and bacterial pathogens and may share similar clinical presentations that make it difficult for physicians to diagnose based on symptoms alone. Syndromic testing with multiplex molecular panels offers clinical labs a way to quickly distinguish between a broad array of respiratory pathogens. In this webinar, Dr. Steve Young of Tricore Reference Laboratories presents a new technology for multiplexed respiratory testing in acutely ill patients. He shares data demonstrating the capabilities of syndromic respiratory testing as well as his impressions on the ease of doing comprehensive syndromic testing using the QIAstat-Dx Analyzer.
-
Learn why a clinical microbiology lab switched to QIAstat-Dx for meningitis/encephalitis
-
Learn how multiplex PCR testing contributes to the diagnosis of respiratory infections
-
Learn why you should transition from culture to RT-PCR for GI testing
-
Learn how multiplex respiratory testing can support better care when it matters most
-
Learn how automated diagnostics can help improve care for patients with ARDS
-
Learn how rapid diagnostic tools can support antimicrobial stewardship programs
-
Learn how rapid multiplex panel tests can improve the diagnosis of gastroenteritis
-
Learn how syndromic panels can support the rapid diagnosis of critically ill patients
-
Learn how a hospital lab validated our new multiplex panel test for meningitis/encephalitis
-
Learn what experts predict for future influenza-like illness seasons in a post-COVID-19 world
-
Learn how clinicians and laboratorians are working together to implement syndromic testing
-
Learn about the clinical outcomes of using dry swabs for respiratory syndromic testing
-
Learn about the role of multiplex testing in the COVID-19 pandemic
-
Learn about the benefits of syndromic testing for acute respiratory illness
QIAstat-Dx resources and further reading